08-Jan-15 Korea’s domestic pharmaceutical R&D industry progressed strongly in 2014, securing approval of its 21st domestically developed drug, Liavax, and the entry of new medicines such as Kanarb and Supect onto the global market. In 2015 new Korean drugs for chemo-induced neutropenia, obesity and arthritis are expected to hit the market, as well as several new vaccines. [image: Business Korea]

18-Dec-14 In trade talks with the US, China has agreed to allow US medicines and medical devices into its markets more quickly. China agreed to “cut red tape” for imports of new and innovative pharmaceuticals and medical devices, said US Commerce Secretary Penny Pritzker. [image: CCTV America]

10-Dec-14 Korea’s National Pension Service is ramping up to focus on investments in overseas healthcare markets in 2015, in the interest of income source diversification. Major Korean corporations such as Samsung have already started investing in hospitals abroad, for example in Turkey. [image: Business Korea]

27-Nov-14 A new OECD report says despite a 10% improvement in life expectancy over the past 20 years, most Asia-Pacific countries still need to step up efforts to give people access to affordable, quality healthcare. Too many people, especially women, cannot get the treatment they need due to high costs, difficulties in getting permission to see a doctor, or a lack of providers in rural areas. [image: OECD]

12-Nov-14 Alibaba has realised its ambition of expanding into the health sector with the launch of Alibaba Health Information Technology, in Oct-14. The newly formed unit was previously Citic 21CN, a company acquired by Alibaba earlier this year. Its drug coding system is seen as the most important asset for Alibaba. [image: Want China Times]